Design of the Dutch Prevention of Influenza, Surveillance and Management (PRISMA) study

Vaccine

Volumn 21, Issue 15, 2003, Pages 1719-1724

  Hak, E ^a   Van Loon, S ^a   Buskens, E ^a   Van Essen, G A ^a   De Bakker, D ^b   Tacken, M A J B ^c   Van Hout, B A ^a   Grobbee, D E ^a   Verheij, Th J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Natl Inst for Primary Health Care   (Netherlands)

^c Centre for Quality of Care Research   (Netherlands)

Author keywords

Cost effectiveness; General practice; Influenza vaccination; Prevention

Indexed keywords

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIABETES MELLITUS; EPIDEMIC; FATALITY; FEMALE; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY; NETHERLANDS; OTITIS MEDIA; PNEUMONIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MIDDLE AGED; NETHERLANDS; ODDS RATIO; POPULATION SURVEILLANCE;

EID: 0037413958     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00520-0     Document Type: Article

References (37)

1. Nichol K.L., Goodman M. The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years. Pharmacoeconomics. 16(Suppl. 1):1999;63-71.
2. Logar M. Microbial aetiology of community-acquired pneumonia in hospitalised patients. Eur J Clin Microbiol Infect Dis. 18:1999;777-782.
3. Connolly A.M., Salmon R.L., Williams D.H. What are the complications of influenza and can they be prevented? BMJ. 306:1993;1452-1454.
4. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P.et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med. 338:1998;1405-1412.
5. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ. 307:1993;982-986.
6. Naghavi N., Barlas Z., Siadata S., Naguib S., Madjid M., Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 102:2000;3039-3045.
7. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons in the community. N Engl J Med. 331:1994;778-784.
8. Hak E., A G., Buskens E., Stalman W.A., de Melker R.A. Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based prospective cohort study in Utrecht, The Netherlands. J Epidemiol Community Health. 52:1998;120-125.
9. Barker W.H. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States 1970-1978. Am J Public Health. 76:1986;761-765.
10. Postma M., Bos J.M., Van Gennep M., Jager J.C., Baltussen R., Sprenger M.J.W. Economic evaluation of influenza vaccination. Assessment for The Netherlands. Pharmacoeconomics. 16(suppl. 1):1999;33-40.
11. Lui K.-J., Kendal A.P. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health. 77:1987;712-716.
12. Nicholson K.G. Impact of influenza and respiratory syncitial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect. 116:1996;51-63.
13. Statens Institut for Medicinsk Teknologivurdering. Influenza vaccination of elderly (with abstract in English). Medicinsk Teknologivurdering 2000;2(1).
14. Sprenger M.J.W., van Naelten M.A.M.G., Mulder P.G.H., Masurel N. Influenza-related excess mortality in The Netherlands. Lancet. 336:1990;382.
15. Anonymous. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR 2000;49:1-38.
16. Couch R.B. Prevention and treatment of influenza. N Engl J Med. 343:2000;1778-1787.
17. van Essen G.A., Kuyvenhoven M.M., de Melker R.A. Implementing Dutch College of General Practitioners' guidelines for influenza vaccination: an intervention study. Br J Gen Pract. 47:1997;25-29.
18. Hak E., van Essen G.A., Stalman W., de Melker R.A. Improving influenza vaccination coverage among high-risk patients: the role of computerised medical records. Fam Pract. 15:1998;138-143.
19. Hak E., Hermens R.P.M.G., Hoes A.W., Verheij Th J.M., Kuijvenhoven M.M., van Essen G.A. Effectiveness of a coordinated nationwide program to improve influenza immunisation rates in The Netherlands. Scand J Prim Health Care. 18:2000;237-241.
20. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 123:1995;518-527.
21. Ohmit S.E., Monto A.S. Influenza vaccine effectiveness in preventing hospitalization for pneumonia among the elderly during influenza A and type B seasons. Int J Epidemiol. 24:1995;1240-1248.
22. Nichol K.L., Wuorenma J., Von Sternberg T. Benefits of influenza vaccination for low-, intermediate- and high-risk senior citizens. Arch Intern Med. 158:1998;1769-1776.
23. Flemming D.M., Watson J.M., Nicholas S., Smith G.E., Swan A.E. Study on the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect. 115:1995;581-589.
24. Meier C.R., Jick S.S., Derby L.E., Vasilakis C., Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 351:1998;1467-1471.
25. Siscovick D.S., Raghunathan T.E., Lin D., Weinmann S., Arbogast P., Lemaitre R.M.et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol. 152:2000;674-677.
26. Valdez R., Narayan K.M., Geiss L.S., Engelgau M.M. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. Am J Public Health. 89:1999;1715-1721.
27. Beasley R., Coleman E.D., Hermon Y., Holst P.E., O'Donnell T.V., Tobias M. Viral respiratory infection and exacerbations of asthma in adult patients. Thorax. 43:1988;679-683.
28. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., Cough R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 283:2000;499-505.
29. Mullooly J.P., Bennett M.D., Hornbrook M.C., Barker W.H., Williams W.W., Patriarca P.A.et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med. 121:1994;947-952.
30. Riddiough M.A., Sisk J.E., Bell J.C. Influenza vaccination. Cost-effectiveness and public policy. JAMA. 249:1983;3189-3195.
31. Maucher J.M., Gambert S.R. Cost-effectiveness analysis of influenza vaccination in the elderly. Age. 13:1990;3-9.
32. Patriarca P.A., Arden N.H., Koplan J.P., Goodman R.A. Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med. 107:1987;732-740.
33. Helliwell B.E., Drummond M.F. The costs and benefits of preventing influenza Ontario's elderly. Can J Public Health. 79:1988;175-179.
34. Hak E., Verheij T.J.M., Van Essen G.A., Lafeber A.B., Grobbee D.E., Hoes A.W. Prognostic factors for influenza-associated hospitalization and death during an epidemic. Epidemiol Infect. 126:2001;261-268.
35. Tacken M.A.J.B., Braspenning J.C.C., van Paasen J., van den Hoogen H.J.M., de Bakker D.H., Grol R.P.T.M. Negen jaar influenzavaccinatie in de huisartspraktijk [in Dutch]. Huisarts Wet. 43:2000;566-567.
36. Rimmelzwaan G.F., De Jong J.C., Bartelds A.I., Dorigo-Zetsma J.W., Fouchier R.A., Osterhaus A.D. Influenza season 1999/2000; composition of vaccine for 2000/2001 [in Dutch]. Ned Tijdschr Geneeskd. 144:2000;1968-1971.
37. Smits A.J., Hak E., Stalman W.A.B., Van Essen G.A., Hoes A.W., Verheij T.J.M. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect. 128:2002;205-211.